Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddys Laboratories informs about press release

Date: 21-02-2019

Dr. Reddys Laboratories has informed about press release titled ‘Dr. Reddy's Laboratories announces the re-launch of its Buprenorphine and Naloxone Sublingual Film after favorable ruling in patent litigation’.

The above information is a part of company’s filings submitted to BSE.